Director, Program Management

The Role

This is an exciting, high-profile, and highly visible Program Management opportunity to advance a first-in-class RAS(ON) Inhibitor through clinical development.

Responsibilities

• Partner with the Project Team Leader (PTL) in defining program strategy, stakeholder management, and overall program leadership topics.
• Establish and maintain functionally integrated project plan and project assumptions (accounting for goals, key objectives, deliverables, risks) to enable accurate project, financial and portfolio analyses for business planning processes.
• Evaluate alternative development scenarios (comprising costs, timelines, risks, and project strategy) during progression of the program through stage gates and as per business need.
• Lead the global development team through the preparation and update of key project documents and communications.
• Lead an efficient information flow within the global cross-functional project team, and internal advisory & governance bodies.
• Demonstrate effective meeting and information management including prioritizing the right topics for discussion, ensuring the objectives of the meeting are achieved, communicating decisions to key stakeholders and ensuring that action items are assigned and completed in a timely manner.
• Serve as the owner of project team information including the project plan, budget and program assumptions as approved by PRG and the Senior Leadership Team.
• Partner with the PTL to ensure the team achieves and maintains a high-level of sustainable performance.
• Apply drug development expertise to coach and mentor project team members to ensure efficient and effective project team operation.
• Identify, recommend, and implement opportunities for streamlining team and business processes.
• Participate in establishment and implementation of project management systems and best practices.
• Coach and mentor members of the Program Management team to ensure a strong bench of future leaders.
• Support new corporate development activities or other initiatives supporting department, portfolio, or corporate needs.

Requirements

B.A. or BSc. in Life Sciences and at least 8 years’ experience in the biotech/pharmaceutical industry with at least 5 years’ direct development project management experience managing cross-functional global development teams.

Qualifications

Broad knowledge of the clinical drug development process and regulations, coupled with strong proficiency in project management practices, tools, and methodology.

Skills

• Expertise in developing and managing project scope, deliverables, risk & resource requirements including, Schedule / Timeline management, and Risk management.
• Excellent interpersonal skills, including clear, succinct, and timely communication and proven ability to foster important relationships with key stakeholders.
• Outstanding verbal and written communication skills with the ability to summarize complex information into simple concepts; has the ability to effectively interact across team line functions as well as with external key stakeholders.
• Proven track record of good decision making and exercising sound judgment.
• Experience using Project Management software to manage project timelines and resources (e.g., MS Project, SmartSheet, OfficeTimeline, and OnePager Pro etc.).
• Strong computer proficiency with MS Office suite, SharePoint and similar document archiving systems.

Benefits

Base Pay Salary Range $211,000 - $264,000 USD

Pay

Base Pay Salary Range $211,000 - $264,000 USD

Schedule

Full-time

Company Information

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.

About the Company

Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status. Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.